Centers for Disease Control and Prevention, Atlanta, Georgia (Dr Scott); and Emory University, Atlanta, Georgia (Drs Culler and Rask).
R. Douglas Scott II, PhD, is an economist for the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention. His research focuses on the use of prevention effectiveness methods and regulatory impact analyses to evaluate programs to prevent health care-associated infections and improve patient safety.
Steven D. Culler, PhD, is a health economist at the Rollins School of Public Health at Emory University. He has published numerous peer-reviewed articles explaining the variation in the use of health care services, estimating the incremental cost of treating selected adverse events, and performing cost-effectiveness studies.
Kimberly J. Rask, MD, PhD, is a primary care physician and health economist, holding joint appointments in health policy and management and medicine at Emory University. Her publications focus on primary care practice, quality improvement, and outcomes measurement. She also serves on national expert panels on value-based purchasing programs and quality measurement.
Corresponding Author: R. Douglas Scott II, PhD, Division of Healthcare Quality Promotion, National Center for Zoonotic and Emerging Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road MS A16, Atlanta, GA 30329-4027 ([email protected]).
The authors have no conflicts of interest to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.
